I am a pharmacist by training and a health outcomes researcher. My interest is in diabetes surveillance and the assessment of the quality and efficiency of health care for type 2 diabetes.
I direct the Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD) based in Alberta Diabetes Institute at the University of Alberta. Through the ACHORD Group, I have lead health outcomes research through epidemiologic, pharmacoepidemiologic, health-related quality of life and economic evaluations.
My colleagues and I are particularly interested in the evaluation of policies and alternative care delivery strategies to improve the quality and efficiency of care in diabetes. Our research has been influential in the development of clinical practice guidelines and health policies related to diabetes care, locally, nationally and internationally.
I have a long history of working with national and provincial agencies, both government and non-government, in areas of diabetes and public health policy and research. I was the co-chair of the Scientific Working Group for the National Diabetes Surveillance System (NDSS) from 2005 to 2009, where I advised the Public Health Agency of Canada on the future direction for the NDSS. From 2007 to 2012 I led the Alberta Diabetes Surveillance System (ADSS), in partnership with Alberta Health and Wellness. I was a member of the Institute Advisory Board for the CIHR Institute of Nutrition, Metabolism and Diabetes. I currently lead the Alberta’s Caring for Diabetes (ABCD) project in partnership with Alberta Health. Currently, I am the Scientific Director for Obesity, Diabetes and Nutrition, Strategic Clinical Network, Alberta Health Services.
In addition, I have served as a reviewer for a number of scientific journals, and research funding agencies, including the Canadian Institutes of Health Research (CIHR), Alberta Innovates – Health Solutions (formerly the Alberta Heritage Foundation for Medical Research), and the Canadian Diabetes Association (CDA). I served on CDA National Research Council, as the chair of Committee III, responsible for funding of population health, health services, clinical/lifestyle intervention and diabetes education research. I am part of the EuroQol (European Quality of Life) Board of Directors and a founding member of the International Diabetes & Cancer Research Consortium Working Group.
PhD, University of Arizona, Tucson, Arizona, 1996
MSc, College of Pharmacy, University of Saskatchewan, 1994
BSP (with Distinction), College of Pharmacy, University of Saskatchewan, 1988
University of Alberta Centennial Professor, 2012
Alberta Pharmacy Centennial Award of Distinction, Alberta College of Pharmacists/Pharmacists Association of Alberta, 2011
University of Alberta Killam Annual Professorship, 2010
Senior Health Scholar Award, Alberta Heritage Foundation for Medical Research, 2009
CDA Young Scientist Award, Canadian Diabetes Association, 2008
Canada Research Chair, Government of Canada, 2007
Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. Dose-response relationship between sulfonylureas and mortality in type 2 diabetes: a population-based cohort study. CMAJ 2006;174:169-174.
Johnson JA, Pohar, SL, Majumdar SR. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care 2006;29:2403-2408.
Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR. Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care 2005;28:783-788.
Johnson JA, Vermeulen SU, Toth EL, Hemmelgarn BR, Ralph-Campbell BA, Hugel G, King M, Crowshoe L. Increasing incidence and prevalence of diabetes among the Status Aboriginal population in urban and rural Alberta, 1995-2006. Can J Pub Health 2009;100(3):231-36.
Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Yasui Y, Johnson JA. Analyzing composite outcomes in cardiovascular studies: Traditional Cox Proportional Hazards Versus Quality of Life Adjusted Survival approaches. Open Medicine 2010;1:e40.
Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD)
funded by the CIHR – Emerging Team Grant: Obesity and Related Diseases, Institute of Nutrition, Metabolism and Diabetes
Alberta’s Caring for Diabetes (ABCD) Project
funded by Alberta Health
Cancer Incidence for Patients with Type 2 Diabetes Exposed to Oral Hypoglycemics: Are there differences between agents?
funded by CIHR
Diabetes, influenza and cardiopulmonary outcomes: The rationale for targeting influenza vaccinations for patients with diabetes
Funded by CIHR